Special Committees in M&A Transactions: Formation, Member Composition, Negotiating and Approval Authority
Mitigating Conflicts of Interest and Director Liability: Business Judgment Rule vs. Entire Fairness Standard
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will examine the use of special committees in M&A transactions where directors or significant shareholders have a conflict of interest. The panel will discuss the formation of a special committee, the committee's role in evaluating and negotiating a proposed transaction, how the committee should interact with the board and third parties, and application of business judgement rule vs. the fairness standard on judicial review.
Outline
- Directors' duty of care in M&A transactions: the business judgment rule
- Conflicts of interest and the "entire fairness" standard of review
- Key components of a special committee
- Disinterested and independent members with sufficient expertise
- Authority to evaluate, negotiate, and reject a transaction in the same manner as a non-conflicted board
- Third-party advisers
- Reasonable compensation
- Deciding when a special committee is necessary
Benefits
The panel will review these and other critical issues:
- What kinds of transactions might make the appointment of a special committee necessary?
- What is the process of creating a special committee? What should the formation resolution say?
- What factors should be considered in appointing members to the committee?
- How does a special committee impact a court's decision to apply the business judgment rule or the fairness standard in examining board actions?
Faculty
Francis J. (Frank) Aquila
Global Head of M&A
Sullivan & Cromwell
During the course of his career, Mr. Aquila has advised on deals totaling more than $1 trillion in value, including... | Read More
During the course of his career, Mr. Aquila has advised on deals totaling more than $1 trillion in value, including advising on more than $100 billion in 2019. He has been called upon by global leaders such as Amgen, Andeavor, Anheuser-Busch InBev, Cheniere Energy, Diageo, Diebold Nixdorf, International Airline Group, Kraft, Navistar International, Novartis, Tiffany & Co. and United Rentals to advise them and their boards of directors on M&A, proxy contests, activism, unsolicited bids, corporate governance, crisis management and a range of matters affecting corporate policy and strategy. Mr. Aquila has been universally recognized as one of the world’s leading mergers and acquisitions lawyers.
Close
James E. Langston
Partner
Cleary Gottlieb Steen & Hamilton
Mr. Langston’s practice focuses on public and private merger and acquisition transactions and activism defense.... | Read More
Mr. Langston’s practice focuses on public and private merger and acquisition transactions and activism defense. He has significant experience in both cross-border and domestic transactions, including conflict transactions, mergers-of-equals, LBOs, joint ventures, and carve-out transactions. Mr. Langston also frequently represents companies and their board of directors on takeover defense and shareholder activism situations. He is a frequent author and lecturer on M&A legal issues.
Close
Youmna Salameh
Director
Houlihan Lokey
Ms. Salameh is a Director in Houlihan Lokey’s Board and Special Committee Advisory practice, where she focuses on... | Read More
Ms. Salameh is a Director in Houlihan Lokey’s Board and Special Committee Advisory practice, where she focuses on public company special committee representations. She has deep expertise in M&A, financing, and special situations involving controlling stockholders, related-party dynamics, inbound offers, and dual-class stock structures. Ms. Salameh specializes in helping clients navigate complex situations and conflict-prone transactions involving the need for heightened sensitivity around corporate governance considerations. Ms. Salameh has more than 15 years of experience in advising companies in a variety of situations, including mergers and acquisitions, capital raises, recapitalizations, and strategic alternatives assessments.
Close